1-13 of 13
Stephen D. Gillies
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma

Wayne L. Furman, Sara M. Federico, Mary Beth McCarville, Barry L. Shulkin, Andrew M. Davidoff, Matthew J. Krasin, Natasha Sahr, April Sykes, Jianrong Wu, Rachel C. Brennan, Michael William Bishop, Sara Helmig, Elizabeth Stewart, Fariba Navid, Brandon Triplett, Victor M. Santana, Armita Bahrami, Gwendolyn Anthony, Alice L. Yu, Jacquelyn Hank, Stephen D. Gillies, Paul M. Sondel, Wing H. Leung, Alberto S. Pappo
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (21): 6320–6328.
DOI: https://doi.org/10.1158/1078-0432.CCR-19-1452
Published: 01 November 2019
View article
PDF
Includes: Supplementary data
Journal Articles

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group

Amy K. Erbe, Wei Wang, Lakeesha Carmichael, KyungMann Kim, Eneida A. Mendonça, Yiqiang Song, Dustin Hess, Patrick K. Reville, Wendy B. London, Arlene Naranjo, Jacquelyn A. Hank, Mitchell B. Diccianni, Ralph A. Reisfeld, Stephen D. Gillies, Katherine K. Matthay, Susan L. Cohn, Michael D. Hogarty, John M. Maris, Julie R. Park, M. Fevzi Ozkaynak, Andrew L. Gilman, Alice L. Yu, Paul M. Sondel
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (1): 189–196.
DOI: https://doi.org/10.1158/1078-0432.CCR-17-1767
Published: 02 January 2018
View article
PDF
Includes: Supplementary data
Journal Articles

A Low-Toxicity IL-2–Based Immunocytokine Retains Antitumor Activity Despite Its High Degree of IL-2 Receptor Selectivity

Stephen D. Gillies, Yan Lan, Thore Hettmann, Beatrice Brunkhorst, Yaping Sun, Stefan O. Mueller, Kin-Ming Lo
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (11): 3673–3685.
DOI: https://doi.org/10.1158/1078-0432.CCR-10-2921
Published: 01 June 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Immunogenicity of the Hu14.18-IL2 Immunocytokine Molecule in Adults With Melanoma and Children With Neuroblastoma

Jacquelyn A. Hank, Jacek Gan, Hyunji Ryu, Amy Ostendorf, Michael C. Stauder, Adam Sternberg, Mark Albertini, Kin-Ming Lo, Stephen D. Gillies, Jens Eickhoff, Paul M. Sondel
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (18): 5923–5930.
DOI: https://doi.org/10.1158/1078-0432.CCR-08-2963
Published: 14 September 2009
View article
PDF
Journal Articles

Radiofrequency Ablation Combined with KS-IL2 Immunocytokine (EMD 273066) Results in an Enhanced Antitumor Effect against Murine Colon Adenocarcinoma

Erik E. Johnson, Brett H. Yamane, Ilia N. Buhtoiarov, Hillary D. Lum, Alexander L. Rakhmilevich, David M. Mahvi, Stephen D. Gillies, Paul M. Sondel
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (15): 4875–4884.
DOI: https://doi.org/10.1158/1078-0432.CCR-09-0110
Published: 29 July 2009
View article
PDF
Journal Articles

Linking Antibody Fc Domain to Endostatin Significantly Improves Endostatin Half-life and Efficacy

Tong-Young Lee, Robert M. Tjin Tham Sjin, Shahla Movahedi, Bissan Ahmed, Elke A. Pravda, Kin-Ming Lo, Stephen D. Gillies, Judah Folkman, Kashi Javaherian
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (5): 1487–1493.
DOI: https://doi.org/10.1158/1078-0432.CCR-07-1530
Published: 03 March 2008
View article
PDF
Journal Articles

A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children's Oncology Group

Kaci L. Osenga, Jacquelyn A. Hank, Mark R. Albertini, Jacek Gan, Adam G. Sternberg, Jens Eickhoff, Robert C. Seeger, Katherine K. Matthay, C. Patrick Reynolds, Clare Twist, Mark Krailo, Peter C. Adamson, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sondel
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (6): 1750–1759.
DOI: https://doi.org/10.1158/1078-0432.CCR-05-2000
Published: 21 March 2006
View article
PDF
Journal Articles

Combination Immunotherapy with Clinical-Scale Enriched Human γδ T cells, hu14.18 Antibody, and the Immunocytokine Fc-IL7 in Disseminated Neuroblastoma

Mario Otto, Raymond C. Barfield, William J. Martin, Rekha Iyengar, Wing Leung, Thasia Leimig, Stanley Chaleff, Stephen D. Gillies, Rupert Handgretinger
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (23): 8486–8491.
DOI: https://doi.org/10.1158/1078-0432.CCR-05-1184
Published: 01 December 2005
View article
PDF
Journal Articles

Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy

Zane C. Neal, Jeannie C. Yang, Alexander L. Rakhmilevich, Ilia N. Buhtoiarov, Hillary E. Lum, Michael Imboden, Jacquelyn A. Hank, Holger N. Lode, Ralph A. Reisfeld, Stephen D. Gillies, Paul M. Sondel
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4839–4847.
DOI: https://doi.org/10.1158/1078-0432.CCR-03-0799
Published: 21 July 2004
View article
PDF
Journal Articles

Improved Circulating Half-Life and Efficacy of an Antibody-Interleukin 2 Immunocytokine Based on Reduced Intracellular Proteolysis

Stephen D. Gillies, Kin-Ming Lo, Christa Burger, Yan Lan, Thomas Dahl, Wai-Keung Wong
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (1): 210–216.
Published: 01 January 2002
View article
PDF
Journal Articles

Augmentation of Antitumor Activity of an Antibody-Interleukin 2 Immunocytokine with Chemotherapeutic Agents

Sylvia A. Holden, Yan Lan, Ana Maria Pardo, John S. Wesolowski, Stephen D. Gillies
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (9): 2862–2869.
Published: 01 September 2001
View article
PDF
Journal Articles

Protective Immunity against Human Carcinoembryonic Antigen (CEA) Induced by an Oral DNA Vaccine in CEA-transgenic Mice

Rong Xiang, Steve Silletti, Holger N. Lode, Carrie S. Dolman, J. Michael Ruehlmann, Andreas G. Niethammer, Ursula Pertl, Stephen D. Gillies, F. James Primus, Ralph A. Reisfeld
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (3): 856s–864s.
Published: 01 March 2001
View article
PDF
Journal Articles

The Ch14.18-GM-CSF Fusion Protein Is Effective at Mediating Antibody-dependent Cellular Cytotoxicity and Complement-dependent Cytotoxicity in Vitro

Ayse Batova, Arvid Kamps, Stephen D. Gillies, Ralph A. Reisfeld, Alice L. Yu
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 4259–4263.
Published: 01 December 1999
View article